Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas

Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas

Blog Article

ObjectiveIntravenous leiomyomatosis (IVL) and benign metastasizing leiomyoma (BML) are uncommon variants of benign uterine leiomyomas with extrauterine manifestations.Categorizing the extent of disease allows clinicians to delineate the clinical spectrum and the level of sophistication for complete surgical resection.MethodsTwelve patients with IVL and BML were reviewed.

They were divided into early versus late stage disease groups, and initial manifestation, clinical characteristics, laboratory values, surgical pathology, Cortisol Support and follow up data were summarized.ResultsPatients were mostly pre- or peri-menopausal and parous.Patients with late stage disease were more likely to present with cardiac symptoms or abnormal findings on chest X-ray, whereas those with early stage disease presented with classical leiomyoma symptoms including heavy menstrual bleeding, increased myoma size, or lower abdominal discomfort.

Tumor marker levels were within normal ranges.A trend of higher neutrophil to leukocyte ratio was observed in the late versus the early stage group (10.4 vs.

1.51, P=0.07); the platelet leukocyte ratio was statistically higher in patients with late stage IVL (0.

23 Island Light vs.0.13, P=0.

04).The overall recurrence rate was 25%.No recurrence was observed in stage I or stage III IVL groups, while 50% of the stage II IVL group showed recurrence in the pelvic cavity.

ConclusionIVL and BML are benign myoma variants with paradoxically metastatic clinical presentation.Careful inquiry of systemic symptoms, the presence of underlying systemic inflammation, and a high index of suspicion are required for preoperative diagnosis.Furthermore, a multidisciplinary approach is necessary to improve outcomes of surgical resection.